Zantac Heartburn Medication Linked to Various Types of Cancer
On April 1, 2020, the FDA requested that all manufacturers of Zantac or other ranitidine medications remove these drugs from the market immediately. This includes both prescription and over-the-counter (OTC) medications.
Ranitidine can form a probable human carcinogen called NDMA when stored in higher than room temperatures. Since Zantac may be stored at unreliable temperatures, it may become unsafe to consume.
In the summer of 2019, the FDA first became aware of independent lab testing that found the ranitidine molecule may be unstable and form NDMA when ingested. In light of this information, ranitidine products may not be available for new or existing prescriptions or OTC use in the U.S.
|
Zantac or ranitidine users who have been diagnosed with the cancers listed below may be able to file a Zantac lawsuit. |
|
|
|
|
|
|
|
|
|
What Is Zantac?
Zantac is a prescription and over-the-counter histamine-2 receptor antagonist, meaning the drug works to decrease the amount of acid created by the stomach.
Zantac’s active ingredient, ranitidine, has been approved by the U.S. Food and Drug Administration (FDA) to prevent and/or relieve heartburn caused by sour stomach and acid indigestion.
In addition to heartburn relief, ranitidine is also approved to:
- Treat and prevent stomach ulcers
- Treat and prevent ulcers in the intestines
- Treat gastroesophageal reflux disease (GERD)
While Zantac may provide heartburn relief, the acid-reducing pills may come with an increased risk of ranitidine cancer.
New research indicates that the presence of NDMA in drugs like Zantac was the result of an “inherent instability” of the ranitidine molecule. In other words, ranitidine has the potential to form millions of nanograms of cancer-causing NDMA at higher temperatures, or in the human body when ingested.
N-nitrosodimethylamine (NDMA) is a known probable carcinogen and is used as an industrial chemical in gasoline, rocket fuel, and other petroleum products.
Why File a Zantac Lawsuit
Recent Zantac lawsuits allege that the drug’s manufacturer, Sanofi, failed to warn users that the drug’s main ingredient is unstable — and may form carcinogenic NDMA.
Lawsuits are being filed across the country, and Zantac law firms are suing Sanofi U.S. Services Inc. for fraud, products liability, and negligence.
If you currently use Zantac or another ranitidine medication — or have used it in the past — and have developed certain cancers, you may be able to file a lawsuit against the drug makers.
Reach out to the Zantac lawyers at Sokolove Law to learn more and get a free legal claim consultation.
Zantac Injuries
The Zantac lawyers at Sokolove Law are currently reviewing cases involving cancer associated with Zantac and other ranitidine prescription and over-the-counter drugs.
Some cancer diagnoses may be the result of exposure to NDMA, which is classified by the World Health Organization (WHO) as “clearly carcinogenic,” or cancer-causing.
NDMA exposure from Zantac may be linked to:
- Bladder cancer
- Breast cancer
- Colon cancer
- Kidney cancer
- Pancreatic cancer
- Stomach cancer
- Testicular cancer
Get Legal Help with a Zantac Lawsuit
If you or a loved one are a present or past user of Zantac or another ranitidine medication and have now been diagnosed with the cancers listed above, you may wish to file a legal claim to pursue a Zantac lawsuit.
A settlement or verdict may result in financial compensation to pay for medical treatments, lost wages, pain and suffering, and other expenses.
Free Legal Consultation
The Zantac attorneys at Sokolove Law know that good health is priceless — but Zantac users who have fallen victim to the drug’s health consequences may be able to seek financial compensation.
Take the first step: Fill out the form on this page for free legal consultation.